- Press Release -

Rockville, Md. The global platelet-rich plasma market is set to reach US$ 391 Mn by 2022 on robust growth, according to Fact.MR. PRP therapy, which uses a platelet gel far more concentrated than normal blood, is prized for speeding the healing of bone and soft tissue, and its uses now stretch from orthopedic surgery and sports injuries to neurological conditions, facelifts and erectile dysfunction.

Orthopedic surgery is the leading application, pure PRP kits lead by product, and North America anchors demand. Cosmetic surgery is the fastest-growing use.

Products, Applications and Settings

Pure PRP kits reach nearly US$ 90 Mn by 2022, holding over a quarter of product revenue but ceding some share. By application, orthopedic surgery leads and reaches nearly US$ 151 Mn by 2022, led by North America, while cosmetic surgery grows fastest, from US$ 62 Mn in 2017 to US$ 96 Mn by 2022 at a 9.2% CAGR. Among end users, dermatology clinics reach nearly US$ 58 Mn in 2017 at about a quarter of revenue and gain share over the period.

Clinical Breadth Drives Demand

The market runs on versatility. As PRP proves useful across a widening set of procedures and delivers faster tissue healing, adoption climbs, though the high cost of therapy remains the main check on growth through the forecast period.

Suppliers and Their Playbook

The field brings together medical device and biopharmaceutical firms.

• Terumo Medical Corporation, Johnson & Johnson, Exactech, Inc., CSL Limited, Arthrex, Inc., Stryker Corporation, Biotest Aktiengesellschaft, and Zimmer Biomet Holdings, Inc. are among the key players in the report.

Reading the Market for Decisions

For manufacturers, growth favours cosmetic and dermatology applications alongside the orthopedic mainstay. Investors get a small, fast-growing market with a firm clinical tailwind. Procurement and clinic teams can plan around orthopedic surgery carrying volume, cosmetic surgery leading growth, and North America offering the largest opportunity through 2022.

About the Report

Fact.MR's study covers the global platelet-rich plasma market for the 2017 to 2022 forecast period, with segmentation by product type, application, end user and region. It sizes each segment, maps the competitive field, and weighs the clinical forces shaping demand. Further detail is available in the platelet-rich plasma market report.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. The firm is known for its syndicated research, custom research and consulting solutions, helping clients make decisions on demand, competition, investment, procurement and future growth.